Healgen COVID-19 IgG/IgM Rapid Test Receives FDA & EUA Approval

Verify Diagnostics is excited to announce that the Healgen COVID-19 Antibody Rapid Test Cassette has received FDA & EUA approval.

COVID-19

The test is distributed by Verify Diagnostics and is an essential diagnostic tool that enables healthcare professionals to make determinations of patients’ status after contracting COVID-19.

Benefits of the Healgen COVID-19 IgG/IgM Rapid Test include:

  • The test is easy to administer and offers reliable results at a fraction of the cost and time of PCR or ELISA tests.
  • Antibody testing allows the determination of patients’ immunity status after contracting and whether someone may have acquired immunity to the virus based on the presence of IgM/IgG antibodies
  • Antibody testing will allow clinicians to develop a better understanding of how the virus spreads and gather community infection data.

The Healgen COVID-19 Antibody tests are now available from Verify Diagnostics.

Verify Diagnostics has 10+ years of providing rapid testing technologies globally. We offer a complete suite of services and tools enabling healthcare professionals to use medical devices as recommended by the manufacturer. We offer our clients a self-guided, online training service, specific to our COVID-19 Tests. This allows healthcare professionals to provide consistent messaging and online training to their front-line staff, specimen collectors, etc. and improve team competency.

www.VERIFYDIAGNOSTICS.COM

[email protected]

866-446-2953

2 responses to “Healgen COVID-19 IgG/IgM Rapid Test Receives FDA & EUA Approval

Leave a Reply

Your email address will not be published. Required fields are marked *

1 × five =